 Heres a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks Biotech stocks that hit 52-week highs April 8 Keros Therapeutics Inc NASDAQ: KROS went public Wednesday and traded 25.5 higher to 20.08, up from the IPO price of 16None of the NYSE- or Nasdaq-listed 